Breakthrough in mRNA vaccines for melanoma Preliminary research shows personalised melanoma mRNA vaccines given with an immunotherapy drug reduce risk of death and recurrence.
First country approves Moderna vaccine targeting Omicron The approval comes in the same week that Monash University was selected to house the first mRNA production facility in the Southern Hemisphere.
TGA releases vaccine-related myocarditis severity details Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.
Booster protection wanes after four months – what does this mean for winter in Australia? The US CDC’s latest report on the durability of booster protection has found a more than 20% decline in effectiveness against emergency department encounters.
Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
How close is a home-grown mRNA COVID-19 vaccine? The first mRNA vaccine candidate developed in Australia should go to clinical trials next year. newsGP looks into whether GPs will one day administer doses.
Government moves to ease concerns over next month’s Pfizer supply The Federal Government says Pfizer has confirmed it will meet its scheduled delivery following reports of a potential shortfall.
Research finds no association between COVID vaccines and miscarriage Pregnant women who are vaccinated against SARS-CoV-2 are no more likely to miscarry than those who are unvaccinated.
Anaphylaxis in less than 1% of ‘highly allergic’ after Pfizer: Study The new research finding also suggests a screening questionnaire could be used to enhance patient safety.
No Moderna access for general practice in 2021 Ten million doses of the mRNA vaccine will be prioritised for pharmacies and workplace vaccination programs, the Department of Health has said.